News | March 14, 2023
Alpla and Inden pharma form joint venture
ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma
ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
Chronic Kidney Disease is a growing epidemic with 850 million people affected worldwide.
The agreement is for USFDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
The Development Center with its state-of-the art laboratories and flexible pilot capacities is set to become Siegfried's global research and development hub for its Drug Products sites, strengthening the global network
These patches can be used in settings where patients need close vital signs monitoring, including cardiac rhythm.
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
The collaboration will focus on developing a localized and sustained-release drug delivery system for oncology patients
Subscribe To Our Newsletter & Stay Updated
